Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Bridges on the Dismissal of the Novartis Patent Challenge
The Economic Times -Efficacy
Abbott’s HIV drug, kaletra, faces pre grant opposition in India, Europe
Abbott Lab’s bid for anti-HIV drug patent to face stiff challenge
Booster shot: US body opposes Abbott’s patent in India, Europe
I-MAK Challenges Patents on Lifesaving HIV Drug Combination in Europe, India
I-MAK Announces: BigPatents India Revolutionizes Indian Patent System
I-MAK speaks to the New Scientist about innovation